Kymera Therapeutics Inc (KYMR) is around the middle of the Biotechnology industry according to InvestorsObserver. KYMR received an overall rating of 45, which means that it scores higher than 45 percent of all stocks. Kymera Therapeutics Inc also achieved a score of 55 in the Biotechnology industry, putting it above 55 percent of Biotechnology stocks. Biotechnology is ranked 55 out of the 148 industries.
KYMR has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on KYMR!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Kymera Therapeutics Inc Stock Today?
Kymera Therapeutics Inc (KYMR) stock is trading at $13.70 as of 12:56 PM on Friday, Nov 3, a gain of $1.62, or 13.41% from the previous closing price of $12.08. The stock has traded between $12.23 and $14.36 so far today. Volume today is 685,865 compared to average volume of 747,331.
Click Here to get the full Stock Report for Kymera Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
